MEMORANDUM AND ORDER
Plaintiffs Barry Leon (“Leon”); ABL Venture Capital, LLC (“ABL”); and OS Research, LLC (“OS Research”) (collectively, “plaintiffs”) bring this action against defendants Igor Shmukler (“Shmukler”); Thinomenon, Inc. (“Thinomenon”); and Gennady Mednikov (“Mednikov”) (collectively, “defendants”), under New York State contract and tort law and federal copyright law, based on defendants’ alleged misappropriation and use of intellectual property, assets, and information owned by OS Research. Plaintiffs seek declaratory and injunctive relief, and damages.
I. Background
A. Factual Background
The following facts are taken from the complaint and the exhibits attached thereto.
Leon, a resident of New York, is the principal and controlling shareholder of ABL, a New York corporation. (Complaint ¶¶ 2-8.) OS Research, a joint venture between ABL, Shmukler, and a non-party, Shiotel Lebovic (“Lebovic”), is a New York corporation. (Id. ¶¶ 4-5.) ABL possesses a 71.59 percent membership and equity interest in OS Research. (Id. ¶ 6.) Thinomenon is an Illinois corporation based in Illinois. (Id. ¶ 8.) Mednikov, an Illinois resident, is Thinomenon’s registered agent, president, and secretary. (Id. ¶¶ 9-10.)
1. OS Research and the Arbitration
Around October 2002, ABL, Shmukler, and Lebovic formed OS Research. (Id. ¶ 15.) ABL, Shmukler, and Lebovic were the sole members, and their business relationship was and remains governed by the “OS Research, LLC Operating Agreement” (the “Agreement”). (Id ¶ 17; Agreement, Complaint Ex. 1.) Shmukler was the officer responsible for day-to-day operations, including hiring, retaining and supervising a team of contract-employee software developers, website designers, and salespeople to create, market, and sell a suite of software products. (Complaint ¶¶ 18-19.)
For ten years, OS Research developed software products and a desktop virtualization suite known as Elusiva. (See id. ¶¶ 28-31.) In approximately May 2011, however, Shmukler abruptly ceased all op
In response and pursuant to a clause in the Agreement requiring “[a]ny controversy, claim or dispute arising out of or relating to this Agreement” to be arbitrated in New York, Leon, ABL, and Letovic brought a July 2011 arbitration against Shmukler in New York. (Id. ¶38.) The moving defendants were not parties to the arbitration, which addressed two issues: the proportions of ownership ABL, Lebovic, and Shmukler held in OS Research and its assets, and whether Shmukler was entitled to control of OS Research’s assets. (Id. ¶¶ 38, 40; Arbitration Award, Complaint Ex. 3.) The arbitrators stated that the claims arose out of Shmukler’s discontinuation of OS Research’s operations and refusal to recognize ABL’s ownership and control of the entity. (See Arbitration Award, at 1.) The arbitrators did not consider claims based on the establishment or operation of any successor entity, or any claims based on other breaches of the Agreement or exploitation of the assets. (See generally id.) They determined that ABL owned 71.59 percent of OS Research and that Shmukler had no right to control or transfer its assets. (Id. at 2; Complaint ¶ 40.) Plaintiffs have been unable to serve Shmukler with the award. (Complaint ¶ 40.)
2. Thinomenon and Mednikov
Plaintiffs allege that Shmukler began planning his exit from OS Research before May 2011, and he incorporated Thinomenon a month after shutting down OS Research and taking Elusiva products and other assets. (Id. ¶¶41, 48.) Documents on file with the Illinois Secretary of State identify Mednikov as Thinomenon’s agent, president, and secretary, but they do not mention Shmukler. (Id. ¶¶ 8-9; Corporation Report, Complaint Ex. 6.) Thinomenon operates using a website at Thinomenon.com. (Id. ¶ 46.) It began selling the Elusiva products in its own name in mid-2011, and it continues to do so. (Id. ¶¶ 47-59.) Plaintiffs allege that Thinomenon’s products are “mere relabelings or revisions of, and are entirely derived from, OS Research’s Elusiva products and website.” (Id. ¶ 55.) Plaintiffs further allege that they have not been compensated for the use of their property; have not received allocations, distributions, or loan repayments as required by the Agreement; and have not been informed of management decisions in accordance with the rights granted them under the Agreement. (Id. ¶¶ 59.)
The specific allegations (factual and legal) against Mednikov are as follows:
(1) Shmukler transferred the assets and intellectual property of OS Research to Mednikov and Thinomenon, “or, in the alternative, has used and is using Mednikov and Thinomenon as a front for his own activities.” (Id. ¶ 62.) Thinomenon has made use of these products and is selling them under a new name. (Id.)
(2) Thinomenon and Mednikov, as Shmukler’s “successors and assigns, have failed to make payments and distributions to ABL under the Operating Agreement” and thus havebreached their contractual obligations to AJBL. (Id. ¶¶ 77-78.)
(8) Because Thinomenon and Mednikov “are successors to Defendant Shmukler’s membership and interest in OS Research,” they “owe fiduciary duties to Plaintiffs.” (Id. ¶ 101.) Defendants allegedly have violated those duties by, inter alia, converting OS Research assets to their own use, interfering with contractual relations, and diverting business opportunities. (Id. ¶ 102.)
(4) Thinomenon and Mednikov are liable for officer misconduct as transferees under N.Y. B.C.L. § 720 because they knew the wrongfulness of any transfer of OS Research assets to Thinomenon. (Id. ¶¶ 105-06.)
(5) Thinomenon and Mednikov discovered OS Research’s trade secrets by wrongful means, because they obtained them from Shmukler with knowledge that they belonged to OS Research and/or elusiva.com, and have exploited those secrets for their own benefit and to the exclusion of plaintiffs. (Id. ¶ 124.)
Plaintiffs seek a declaratory judgment (1) declaring that (a) any purported transfer, sale, or assignment by Shmukler is null and void; (b) Thinomenon is an alter ego of, functional continuation of, and successor to OS Research; (c) ABL holds 71.59 percent of the membership and equity interest of Thinomenon; and (2) ordering defendants to transfer control of Thinomenon and its assets to ABL. (Id. ¶ 69.) Plaintiffs also bring causes of action for breach of contract, accounting, injunctive relief, breach of fiduciary duty, officer misconduct, conversion, unjust enrichment, misappropriation of trade secrets, copyright infringement, and tortious interference with prospective business opportunities.
B. Procedural Background
Plaintiffs filed the complaint on June 4, 2013. Thinomenon and Mednikov moved to dismiss on August 15, 2013. Plaintiffs opposed on September 19, 2013. Defendants replied on October 18, 2013. The Court held oral argument on November 13, 2013.
II. Standard of Review
A. Personal Jurisdiction
On a motion to dismiss for lack of personal jurisdiction pursuant to Rule 12(b)(2), the plaintiff bears the burden of showing the court has jurisdiction over the defendant. Metro. Life Ins. Co. v. Robertson-Ceco Corp.,
B. Failure to State a Claim
In reviewing a motion to dismiss pursuant to Federal Rule of Civil Procedure
The Supreme Court clarified the appropriate pleading standard in Ashcroft v. Iqbal, setting forth a two-pronged approach for courts deciding a motion to dismiss.
The Court notes that in adjudicating this motion, it is entitled to consider: “(1) facts alleged in the complaint and documents attached to it or incorporated in it by reference, (2) documents ‘integral’ to the complaint and relied upon in it, even if not attached or incorporated by reference, (3) documents or information contained in defendant’s motion papers if plaintiff has knowledge or possession of the material and relied on it in framing the complaint, (4) public disclosure documents required by law to be, and that have been, filed with the Securities and Exchange Commission, and (5) facts of which judicial notice may properly be taken under Rule 201 of the Federal Rules of Evidence.” In re Merrill Lynch & Co.,
III. Discussion
Although Mednikov raises a jurisdictional question, the question is intertwined with the sufficiency of the complaint’s allegations as to his individual liability. Therefore, the Court first considers whether the 2011 arbitration bars this lawsuit. As discussed in detail below, the Court concludes that res judicata does not apply and, thus, denies the motion to dismiss on that ground. The Court then addresses whether it has personal jurisdiction over Mednikov. The Court concludes that, even construing the allegations in the light most favorable to plaintiffs, plaintiffs fail to make a prima facie showing of personal jurisdiction. Plaintiffs’ allegations that Mednikov is a successor in interest or that he is subject to long-arm jurisdiction are insufficiently developed to permit judgment as to whether personal jurisdiction is appropriate. However, notwithstanding the failure to allege sufficient facts to
A. Res Judicata
Defendants argue that the 2011 bars the complaint under the doctrine of res judicata. The Court disagrees.
1. Legal Standard
The doctrine of res judicata, otherwise known as claim preclusion, prevents parties from re-litigating issues in subsequent litigation that were or could have been litigated in a prior action. See Allen v. McCurry,
2. Application
Res judicata does not apply in this case for two independent reasons.
First, neither the moving parties nor OS Research — which itself was the subject of the prior arbitration — were parties to the prior arbitration. Under New York and federal law, the question is whether Thinomenon’s and Mednikov’s interests were represented in the prior action. Chase Manhattan Bank, N.A. v. Celotex Corp.,
Second, given the date of the arbitration and the fact that the complaint alleges misconduct after the arbitration, the claims here could not have been raised during the initial arbitration. See Beck-ford,
Accordingly, the Court denies the motion to dismiss based on res judicata grounds.
B. Personal Jurisdiction over Mednikov
Defendants also move to dismiss Mednikov for lack of personal jurisdiction. Plaintiffs argue (1) their allegations of successor liability are sufficient, without more, to give the Court personal jurisdiction over Mednikov; and (2) the Court has jurisdiction over Mednikov pursuant to N.Y. C.P.L.R. (“CPLR”) 302(a)(1) and (a)(3)(h).
1. Successor Liability-Based Jurisdiction
As a threshold matter, plaintiffs’ complaint does not assert jurisdiction pursuant to a successor liability theory and Federal Rule of Civil Procedure 25(c). {See Complaint ¶ 13.) In any event, there is an insufficient basis at this juncture to conclude that the successor liability theory applies to Mednikov.
It is well-settled “that when a person is found to be a successor in interest” to a person over whom the court has personal jurisdiction, “the court gains personal jurisdiction over [the successor] simply as a consequence of their status as a successor in interest, without regard to whether they had any other minimum contacts with the state.” LiButti v. United States,
Even if the theory were applicable to the relationship between two individuals, Shmukler and Mednikov, plaintiffs fail to make a prima facie showing of successor liability. Plaintiffs cite the allegations in paragraphs 27, 69, 76-77, 90, and 101 of the complaint. Paragraphs 27, 76, and 90 recite the terms of the Agreement; paragraph 69 is plaintiffs’ request that the Court declare Thinomenon the successor to OS Research — not a factual allegation; and paragraphs 77 and 101 allege that Mednikov is Shmukler’s successor and assign because Shmukler transferred OS Research’s assets and intellectual property to Thinomenon and Mednikov. In short, the facts of the alleged transfer of assets to Thinomenon and Mednikov are completely undeveloped. For example, there are no specific allegations of actions Mednikov took to assume Shmukler’s obligations pursuant to the Agreement, or specific factual allegations that Shmukler transferred or assigned his interests to Mednikov. The complaint, in fact, implies that Shmukler retains significant interests in the OS Research assets and information. Therefore, the Court concludes that the bare factual allegations against Mednikov in the- complaint are insufficient, without more, to establish personal jurisdiction over him pursuant to a successor liability theory.
2. Long-Arm Jurisdiction
Plaintiffs also argue that Mednikov should be subject to long-arm jurisdiction under CPLR 302(a)(1) and 302(a)(3)(ii) pursuant to his role as President of Thinomenon. (See Opposition, at 12-18.) ' As set below, plaintiffs’ allegations are insufficient to make a prima facie showing. However, plaintiffs have made a sufficient showing to warrant limited jurisdictional discovery before this issue is decided,
a. Legal Standard
“In diversity or federal question cases the court- must look first to the long-
To establish personal jurisdiction under CPLR 302(a)(1), two requirements must be met: (1) the defendant, either personally or through an agent, must have transacted business within the state; and (2) the claim asserted must arise from that business activity. Sole Resort, S.A. de C.V. v. Allure Resorts Mgmt., LLC,
In addition, it is well-settled that New York state long-arm jurisdiction is appropriate over a person or agent who “commits a tortious act without the state causing injury to person or property within the state ... if he ... expects or should expect the act to have consequences in the state and derives substantial revenue from interstate or international commerce.” CPLR 302(a)(3)(ii); see LaMarca v. PaK-Mor Mfg. Co.,
b. Application
A review of the complaint and the opposition demonstrates that plaintiffs’ theory of personal jurisdiction hinges on Mednikov’s role as President. (E.g., Opposition at 6 (“[B]y virtue of his position as President of Thinomenon, the only plausible inference is that Mednikov was involved in all of this tortious activity, which is sufficient to state claims against him in his individual capacity without the necessity of piercing the corporate veil.”); id. at 18 (“Moreover, even if Mednikov has never set foot in New York, Thinomenon’s activities in New York subject him to jurisdiction here [under § 302(a)(1) ] as the Company’s President under principles of agency.”).) As Mednikov argues, however, the complaint is devoid of any specific factual allegations that he has acted unlawfully and is subject to personal jurisdiction.
First, there are no allegations that Mednikov is Thinomenon’s alter ego. There also are no allegations that he is responsible for Thinomenon’s daily management, that he has signed contracts relating to New York (or other forums), that he assisted Shmukler in absconding with any assets from OS Research, or that he has been responsible for developing Thinomenon and its products. Even if Mednikov were responsible for daily management, that fact and his officer title alone cannot suffice to impute jurisdiction under an agency theory, because in that case any corporate executive of a similar business would be subject to long-arm jurisdiction in New York so long as the corporation transacted business here. See Rainbow Apparel,
Second, the balance of the allegations do not establish personal jurisdiction under CPLR 302(a)(3)(ii). Plaintiffs argue that, based on Shmukler’s ties to Thinomenon and Thinomenon’s actions, “[t]he only reasonable inference is that Mednikov knew or should have known (1) about Plaintiffs and their location in New York, (2) that Shmukler had started Thinomenon with Plaintiffs’ assets and intellectual property in violation of the Agreement, and (3) that Thinomenon and Mednikov’s tortious conduct would cause damage to Plaintiffs in New York.” (Opposition, at 14.)
As explained supra, the general principle is that a corporate officer who commits or participates in a tort, even if it is in the course of the officer’s duties on behalf of the corporation, may be held individually liable. Bano v. Union Carbide Corp.,
Therefore, even construing the allegations in the complaint in the light most favorable to plaintiffs, the Court concludes that the lone allegation in ¶ 124 is insufficient to be a prima facie showing of personal jurisdiction under CPLR 302(a)(3)(ii), given the absence of any specific allegations as to Mednikov’s precise role as President at Thinomenon and his involvement in the alleged misconduct. There is no “factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Iqbal,
c. Limited Jurisdictional Discovery
It is well settled under Second Circuit law that, even where plaintiff has not made a prima facie showing of personal jurisdiction, a court may still order discovery, in its discretion, when it concludes that the plaintiff may be able to establish jurisdiction if given the opportunity to develop a full factual record. See, e.g., In re Magnetic Audiotape Antitrust Litig.,
District courts have considerable discretion in determining how to best handle jurisdictional questions, and generally may allow plaintiff to conduct limited discovery with respect to the jurisdictional issue. Such discovery has typically been authorized where the plaintiff has made a threshold showing that there is some basis for the assertion of jurisdiction[,] facts that would support a colorable claim of jurisdiction.
Id. at *5 (internal quotation marks and citations omitted); see also Viko v. World Vision, Inc., No. 2:08-CV-221,
Here, the allegations in the complaint are sufficient to warrant jurisdictional discovery. In particular, as noted above, the complaint alleges, inter alia, the following: (1) Thinomenon was incorporated one month after Shmukler shut down OS Research; (2) documents on file with the Illinois Secretary of State identify Mednikov as Thinomenon’s president, secretary and agent for service; and (3) Thinomenon has distributed, as its own, software products bearing the Elusiva name while Mednikov has served as President, and continues to distribute software derived from Elusiva to the present date. Based upon these and the other allegations in the complaint, the Court concludes, in its discretion, that plaintiffs’ contentions of personal jurisdiction are colorable and that they should have the opportunity to engage in limited discovery as to the jurisdictional questions. The parties shall meet-
IV. Conclusion
For the foregoing reasons, the motion to dismiss on grounds of res judicata is denied. The motion to dismiss the compliant with respect to Mednikov for lack of personal jurisdiction is denied without prejudice to renewal after the completion of limited jurisdictional discovery.
SO ORDERED.
Notes
. It is well-settled that, in considering a motion to dismiss, courts may take judicial notice of documents attached to, integral to, or referred to in the complaint, as well as documents filed in other courts and other public records. See, e.g., Global Network Commc'ns, Inc. v. City of New York,
. A motion to dismiss on res judicata grounds is considered under Rule (12)(b)(6). See Thompson v. Cnty. of Franklin,
. The parties do not dispute whether the Court has personal jurisdiction over Thinomenon. Plaintiffs also state that they reserve the issue of jurisdiction under CPLR 302(a)(3)(i) because they "do not have firsthand knowledge of Mednikov's activities in New York.” (Opposition, at 13 n. 5.)
. Rule 25(c) provides: "In case of any transfer of interest, the action may be continued by or against the original party, unless the court upon motion directs the person to whom the interest is transferred to be substituted in the action or joined with the original party.” Fed.R.Civ.P. 25(c).
. In Transfield ER Cape Ltd. v. Indus. Carriers, Inc.,
. Thus, the same standard for personal jurisdiction applies to plaintiff's claim under the Copyright Act, see, e.g., Davis v. United States, No. 03 Civ. 1800(NRB),
